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Executive Summary Background
Worldwide an estimated 200 million women and girls have been subjected to female genital mutilation (FGM/C), a traditional practice involving partial or total removal of external genitalia for non-medical reasons. Previous research suggests that FGM/C may be associated with increased risk of acquiring human immunodeficiency virus (HIV). However, there is limited research on the association between HIV and FGM/C. Studies investigating the association between male circumcision and HIV have demonstrated the protective effect of male circumcision. Given that, in some settings, FGM/C and male circumcision are considered "equivalent" procedures, it is important to investigate the effect of FGM/C on the likelihood of HIV infection for women in practising communities.
Methods
This study examined the relationship between HIV prevalence, FGM/C status and key background characteristics such as age, education, household wealth, marital status, parity and residence among women aged 15 to 49 years. We analysed cross-sectional data from the Demographic and Health Surveys (DHS) implemented in the four sub-Saharan Africa countries for which data on HIV and FGM/C were available: Ethiopia (2005), The Gambia (2013), Kenya (2003 and 2008-09) , and Sierra Leone (2008 and . Datasets were analysed separately for each country. Using datasets where a statistically significant association was observed between HIV prevalence and FGM/C status, we adjusted for potential confounders and applied multilevel logistic models to explore the correlates of HIV infection and their association with FGM/C.
Results
The rate of FGM/C was high (>70%) in all countries except Kenya (28.7% in 2008-9 and 33.1% in 2003) . FGM/C types I (partial or complete removal of the clitoris and/or the clitoral hood) and II (partial or complete removal of the clitoris and labia minora; and, in some cases, the labia majora) were predominant in all countries except Ethiopia. In Ethiopia type III (removal of the labia minora and/or labia majora, followed by forcing the wound edges together to create a seal, for example through stitching) was common. HIV prevalence ranged from 1.7 percent (Ethiopia 2005) to 8.7 percent (Kenya 2003) . There was no statistically significant association between FGM/C status and HIV prevalence among women in Ethiopia, The Gambia and Sierra Leone. In contrast, in the Kenya 2003 and 2008-2009 samples, cut women were less likely than uncut women to be HIV+, and this difference was statistically significant both in the bivariate analysis (OR 0.65, p<0.022 in 2008-09; OR 0.56, p<0.001 in 2003) and after adjustment for potential confounders (AOR 0.49, p=0.002 in 2008-09; AOR 0.60, p=0.01 in 2008-09).
Conclusions
Findings are inconclusive. The reason for the inconsistent findings across the countries studied is unclear, but may be related to study limitations such as the cross-sectional design (which limits causal inferences), the possibility of other pathways of association (not included in the analyses) and the considerable geographical variation in HIV prevalence (which makes it difficult to assess its association with FGM/C particularly in low HIV-prevalence settings). Considering that FGM/C causes trauma to the genitalia, which can increase susceptibility to sexually transmitted infections, further research is warranted.
Introduction Background
Female genital mutilation/cutting (FGM/C) is the partial or total removal of the external female genitalia for non-medical reasons. About 200 million women and girls across a range of African, Middle Eastern and Asian countries have experienced FGM/C (UNFPA-UNICEF, 2016), with millions more at risk of being cut during their lifetimes.
Apart from its known association with complications such as obstructed labour and urinary fistulas (Mwanri and Gatwiri, 2017) , psychological distress (Adelufosi et al., 2017) , and sexual dysfunction (Abdel-Azim, 2013 , Biglu et al., 2016 , FGM/C has been postulated to increase the risk of HIV infection (e.g. Brady, 1999) . However, HIV as an additional consequence of FGM/C has not been extensively studied.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates that approximately 37 million people were living with HIV worldwide as of 2016 and that almost the same number had died of HIV-related complications over the previous 25 years (UNAIDS, 2016) . Two-thirds of all new HIV infections occur in sub-Saharan Africa, where women (and girls) are at higher risk of infection than men (and boys). This gender difference can be attributed to socio-cultural and gender norms that tend to disempower women in sexual relationships and may affect women's ability to negotiate safer sex with male partners (see e.g. Ramjee and Daniels, 2013) . The gender disparity may also reflect biological factors, as susceptibility to HIV infection may be higher for women than for men (Mastro and de Vincenzi, 1996, Royce, Sena, Cates et al., 1997) .
The prevalence of HIV shows regional variation throughout sub-Saharan Africa. Rates of HIV infection are highest in some parts of Southern Africa, where, incidentally, FGM/C is rarely practised, as well as in some parts of Western Africa, where the milder forms of FGM/C (types I 1 and II 2 ) predominate. In African regions where the most severe form of FGM/C (type III 3 ) is common, HIV prevalence tends to be low.
Existing Literature
At the population level, FGM/C appears to have a negative association with HIV. However, at the individual level, some experts have suggested that FGM/C may increase HIV risk among women (Brady, 1999) . A recent literature review (Noah-Pinheiro, 2017) identified 14 quantitative studies conducted in several African countries with relevant data for an investigation of FGM/C and HIV at the individual level. The studies from both peer-reviewed (n=11) and grey literature (n=3), were selected based on the following predetermined criteria, even if they did not explicitly set out to explore a link between FGM/C and HIV: (1) FGM/C was an independent variable, and (2) HIV status was confirmed by a laboratory test.
Though observational in design, the selected studies were acceptable because the review's aim was to investigate an association between FGM/C and HIV, not to establish a causal relationship. The review assessed the measurement of FGM/C status (exposure) and HIV infection (outcome); control for potential confounders; sample source; sample size/power considerations (including prevalence of FGM/C and HIV); and response rate. The 14 studies were then rated based on criteria outlined in a Department for International Development (DFID) guidance document 4 : conceptual framing, openness and transparency, cogency, appropriateness and rigour, validity, reliability and cultural sensitivity. Additional rating criteria included effect size and journal impact factor.
Findings from the rating exercise were as follows:
• Three of the 14 studies were determined to be low quality, 10 were of moderate quality, and one was of high quality.
• Important limitations in study design affecting most studies included:
o Poor statistical power o Limited adjustment for potential confounders o Measurement of FGM/C status by self-reporting
• Four studies failed to find a statistically significant association between FGM/C and HIV, six found a negative association, two found a positive association and two reported indirect associations.
• In general, studies that examined data from non-representative samples of women (such as antenatal clinic clients or hospitality workers) were equivocal. Those using data from nationally-representative samples of women mostly found a negative association, except for the two studies set in Kenya, which elicited indirect associations (positive and negative).
No generalities could be made about data sources where a positive association was found.
• The review concluded, with limited confidence, that FGM/C has the anticipated positive association with HIV, and called for further research.
Aim
This study adds to existing literature by examining the relationship between HIV prevalence, selfreported FGM/C status and key background and sexual behaviour-related characteristics of women aged 15 to 49 years in four countries: Ethiopia, The Gambia, Kenya and Sierra Leone.
Methods
Design
We analysed cross-sectional data from Demographic and Health Surveys (DHS) implemented in the four countries where data on HIV and FGM/C status was available. These countries included:
Ethiopia (2005), The Gambia (2013), Kenya (2003 Kenya ( , 2008 Kenya ( -2009 and Sierra Leone (2008, 2013 Variables FGM/C status was the primary independent variable. Respondents were asked, "Have you ever been circumcised?" Response options were "yes", "no", or "don't know". Only women who responded "yes" were classified as being cut.
We included sociodemographic variables that have been found to be associated with FGM/C and/or HIV for descriptive purposes and for use as controls in multivariate analyses: age (Igwegbe & Egbuonu, 2000; Johnson & Way, 2006) , rural-urban residence (Yoder et al., 2004) , region (Johnson & Way, 2006 , Yoder et al., 2004 , religion (Okonofua et al., 2002 , Yoder et al., 2004 , ethnicity (Okonofua et al., 2002 , Yoder et al., 2004 , household wealth status (Johnson & Way, 2006) , education (Igwegbe & Egbuonu, 2000 , Okonofua et al., 2002 and marital status (Johnson & Way, 2006 , Okonofua et al., 2002 . We used standard five-year age cohorts in this analysis: ages 15-19; 20-24; 25-29; 30-34; 35-39; 40-44; and 45-49 . Household wealth was assessed using a wealth index constructed through a principal components analysis of items, assessing housing characteristics and amenities as well as household ownership of various assets. We also included the following reproductive, behavioural and health-related measures that may be associated with FGM/C and/or HIV: parity (Humphrey et al., 2007) , number of lifetime sexual partners (Choudhry et al., 2015) , recent sexual activity (sexual intercourse in the 12 months preceding the survey), experience of sexually transmitted infections (STIs) or STI symptoms such as abnormal vaginal discharge or a genital sore or ulcer (Okonofua et al., 2002) in the 12 months preceding the survey, and exposure to mass media (LaCroix et al., 2014) .
Statistical Analysis
We computed descriptive statistics to explore variations in women's HIV prevalence by FGM/C status and by key background characteristics. Due to sample size limitations (HIV prevalence was relatively low in three out of the four countries) we conducted a limited analysis to explore associations between FGM/C status and HIV prevalence in Ethiopia, The Gambia and Sierra Leone. For Kenya, which had data with relatively high HIV prevalence, we conducted a multivariate analysis. We calculated confidence intervals (CIs) around the HIV prevalence point estimates for women with and without FGM/C and noted statistically significant differences. Datasets were analysed separately for each country (and for each survey round for Kenya and Sierra Leone) and were not pooled.
For the 2003 and 2008-2009 Kenya datasets (where a significant association was observed between FGM/C status and HIV prevalence), multilevel logistic modelling was applied to explore the determinants of HIV and their association with FGM/C. Models included the following variables: FGM/C status, residence, age group, education, wealth quintile, marital status, parity, recent sexual activity (past 12 months), number of lifetime sexual partners, STI or STI symptoms within the last 12 months and exposure to mass media.
The DHS data have a hierarchical structure with individuals nested within clusters, which are nested within regions. In the multilevel analysis, regions constituted the highest (third) level, while clusters (primary sampling units) within regions constituted the second level. Each of the independent variables were included separately as a fixed effect to determine its association with HIV (univariate analysis, Model 1). In Model 2, we adjusted the association of HIV and FGM/C for these independent variables. In all analyses, including the bivariate analysis, we accounted for clustering and the hierarchical nature of the data by including random effects of clusters nested within regions nested within a country. In addition, we applied sample weights as provided in the DHS datasets. In all analyses, a p-value less than 0.05 was considered statistically significant.
Results
HIV Prevalence and FGM/C Status
As shown in Table 1 , rates of FGM/C were high (>70%) in all countries except Kenya (28.7% in 2008-9 and 33.1% in 2003) . Types I and II FGM/C were predominant in all countries apart from Ethiopia, where Type III was common (data not shown). Overall, HIV prevalence ranged from 1.7% (Ethiopia) to 8.7% (Kenya 2003). In Kenya, HIV prevalence was significantly lower among cut women compared to uncut women in both surveys (Table 2) . Figures 1 and 2 show the HIV prevalence by FGM/C status in the 2003 and 2008-09 surveys, respectively. HIV prevalence was not associated with FGM/C status in the other countries (Table 2) . 
Analyses of Kenya DHS 2003 and 2008-2009
The results of the additional analyses on the relationship between HIV prevalence and FGM/C status in the 2003 and 2008-09 Kenya DHS (KDHS) datasets are shown in Table 3 (descriptive analysis) and Table 4 (adjusted analysis). In general, women who were cut were less likely than those who were uncut to be HIV+ in both unadjusted (OR 0.65 [0.45, 0.94] 
Age
In the sample, Kenyan women who were aged 20 years or older were generally more likely to be HIV+ than those ages 15 to 19 years in both Kenya survey rounds, in the unadjusted analysis. After adjustment, however, a mixed pattern is observed. In the 2008-2009 multivariate models, age cohort was no longer associated with HIV status, whereas in 2003, women in all age groups between 20 and 44 years were more likely to be HIV+ compared to those aged 15-19 years, with the highest odds among those aged 25-29 years (AOR 3.58 [1.73, 7.42] ) and 30-34 years (AOR 3.07 [1.36, 6.91]).
Residence
Rural Kenyan women in the sample were less likely than their urban counterparts to be HIV+ in the unadjusted (OR 0.54 [0.38, 0.78]) analyses in 2008-2009. However, the adjusted odds ratio is only marginally statistically significant (AOR 0.59 [0.35, 1.01]). Loss of statistical significance in the adjusted analysis of 2003 data is similarly observed.
Education
No clear pattern was observed by women's education level in the 2008-2009 KDHS. In the 2003 KDHS, women with primary education were more likely than those without any education to be HIV+ (AOR 2.55 [1.17, 5.56] ). Those with secondary and higher education were just as likely as women without education to be HIV+.
Household Wealth
In the 2008-2009 adjusted model, women in the richest quintile were significantly more likely to be HIV+ than women in the poorest quintile (AOR 2. 16 [1.05, 4.43] ). In the 2003 KDHS, the odds of being HIV+ rose with increasing wealth in the unadjusted analysis. However, only women in the richest two quintiles were significantly more likely to have HIV (AOR 2.28 [1.14, 4 .55] and AOR 2.57 [1.18, 5.58] , respectively) than women in the poorest quintile in the multivariate analysis.
Marital Status
In both surveys, women in monogamous and polygamous unions had higher odds of being HIV+ than never married women in the unadjusted models (2008-09: 
Parity
In general, women with one or more children were more likely to be HIV+ in the unadjusted analysis for both surveys, compared to those with no children. After adjustment, in the 2008-2009 survey, this finding still holds, except for the odds ratio related to having five or more children, which was only marginally statistically significant (AOR 2.25 [0.99, 5.10]). In 2003, only women with one child were more likely than those with no children to be HIV+.
Lifetime Number of Sexual Partners
In 2008-2009 survey, only women with one partner were more likely to be HIV+ than the reference group. After adjustment, models including the categories "multiple partners" and "missing" did not converge in both survey rounds due to small cell sizes, so no inferences can be made about whether the associations observed hold in multivariate models. In the unadjusted models based on the 2003 KDHS, women with one (OR 2.04 [1.45, 2.85]) or multiple (OR 4.11 [1.69, 10 .04]) partners were more likely to be HIV+ than women who reported no sexual partners.
Recent Sexual Activity
Recent sexual activity was not associated with HIV status in the 2008-09 sample. In 2003, women reporting recent sexual activity had a higher likelihood of being HIV+ in the unadjusted models. However, this association was non-significant in the adjusted model.
Sexually Transmitted Infection within the Past 12 months
Women who reported STI or STI symptoms in the 12 months preceding the survey were more likely to be HIV+ than those who report otherwise, in both unadjusted and adjusted analysis, in both surveys (AOR 2.09 [1.20, 3.66] in 2008-09; AOR 1.91 [1.01, 3.62] in 2003) .
Exposure to Mass Media
There was no relationship between women's exposure to mass media (radio) and HIV status in both surveys. 
Discussion
This study represents a limited analysis of six nationally-representative population-based surveys to explore the association between HIV prevalence and FGM/C status among women aged 15 to 49 years in four countries (Ethiopia, The Gambia, Kenya and Sierra Leone). We found no difference in HIV prevalence between women who have undergone FGM/C and uncut women in Ethiopia, The Gambia and Sierra Leone. In contrast, we found a negative association between FGM/C status and HIV prevalence in both the Kenyan surveys. The negative association remained significant when we controlled for demographic and behavioural variables that in other studies have been associated with HIV prevalence such as marital status, whether a woman was sexually active, parity, lifetime number of sexual partners and experiencing an STI.
The negative association between FGM/C and HIV found in the Kenya samples conflicts with the theory that FGM/C increases risk of HIV for cut women. The reasons for this finding are not immediately clear. However, previous studies using Kenya DHS data have proposed that cut women may limit engagement in sexual intercourse and may be less likely to engage in pre-marital and extramarital sex (e.g. Yount and Abraham, 2007) . In addition, the regional variation in FGM/C and HIV status in Kenyathe north eastern region ranking highest in FGM/C prevalence while simultaneously having one of the lowest HIV prevalencemakes it difficult to ascertain an association between HIV and FGM/C. Previous studies using Kenya DHS data (Maslovskaya et al., 2009, Yount and Abraham, 2007) found that FGM/C and HIV may be indirectly associated through various pathways.
Study findings should be interpreted in light of several limitations. Firstly, HIV prevalence is relatively low in three of the four countries (Ethiopia, The Gambia, Sierra Leone). Thus, the number of HIV+ women when assessed by FGM/C status (and, further, by background sub-groups) is very small (<25) in three of the four countries. The small numbers of HIV+ women make it difficult to reach meaningful conclusions on the association between HIV prevalence and FGM/C status, whether nationally, or by background or behavioural characteristics. The Kenya 2003 Kenya and 2008 Kenya -2009 surveys are the only ones with large enough numbers of HIV+ women to reach somewhat reliable conclusions, although as stated earlier, the marked regional variation in HIV and FGM/C prevalence may mask any associations. Future research should use data from moderate HIV prevalence countries to yield more robust analyses.
Secondly, the DHS datasets used self-reported FGM/C status, which is known to be less reliable than clinical exam (Elmusharaf, Elhadi & Almroth, 2006) . While recognising that it is not feasible to conduct clinical exams during DHS implementation, studies using other types of samples or data sources may benefit from augmentation with clinical records, where available.
Lastly, only women who affirmatively responded that they had been cut were classified as having FGM/C. It is possible, however, that some of those who responded "don't know" may have been cut. Future analyses should compare the characteristics of women who answered "don't know" to those who answered "yes" and to those who answered "no", to explore the possibility of recoding FGM/C status, for sensitivity analyses.
Conclusions
Findings were inconsistent across the country samples studied. This study found no statistically significant difference in HIV prevalence between women with FGM/C and those without in Ethiopia, The Gambia and Sierra Leone. In contrast, cut women in Kenya were less likely to be HIV positive
